Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burrows

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infectionJohn J Miles, Duangtawan Thammanichanond, Sarah Moneer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptabilityScott R Burrows, Zhenjun Chen, Julia K Archbold, et al.
Neurology|July 15, 2011
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR M Lucas, A-L Ponsonby, K Dear, et al.
The Journal of Experimental Medicine|August 27, 2003
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognitionWhitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, et al.
Immunity|January 13, 2010
T cell allorecognition via molecular mimicryWhitney A Macdonald, Zhenjun Chen, Stephanie Gras, et al.
Science (New York, N.Y.)|September 11, 1992
Energetic Charged-Particle Phenomena in the Jovian Magnetosphere: First Results from the Ulysses COSPIN CollaborationJ A Simpson, J D Anglin, A Balogh, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8<sup>+</sup> T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infectionJohn J Miles, Duangtawan Thammanichanond, Sarah Moneer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptabilityScott R Burrows, Zhenjun Chen, Julia K Archbold, et al.
Neurology|July 15, 2011
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR M Lucas, A-L Ponsonby, K Dear, et al.
The Journal of Experimental Medicine|August 27, 2003
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognitionWhitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, et al.
Immunity|January 13, 2010
T cell allorecognition via molecular mimicryWhitney A Macdonald, Zhenjun Chen, Stephanie Gras, et al.
Science (New York, N.Y.)|September 11, 1992
Energetic Charged-Particle Phenomena in the Jovian Magnetosphere: First Results from the Ulysses COSPIN CollaborationJ A Simpson, J D Anglin, A Balogh, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8<sup>+</sup> T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 38